Decreased cellular activity and replicative capacity of osteoblastic cells isolated from the periarticular bone of rheumatoid arthritis patients compared with osteoarthritis patients

Arthritis and Rheumatism

Volumn 43, Issue 10, 2000, Pages 2178-2188

  Yudoh, Kazuo ^a   Matsuno, Hiroaki ^a   Osada, Ryusuke ^a   Nakazawa, Fujio ^a   Katayama, Rie ^a   Kimura, Tomoatsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; PROCOLLAGEN C PROTEINASE;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TELOMERE;

AGED; ARTHRITIS, RHEUMATOID; BETA-GALACTOSIDASE; CELL AGING; CELL DIVISION; CELLS, CULTURED; COLORING AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOBLASTS; TELOMERASE; TELOMERE;

EID: 0033784027     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200010)43:10<2178::AID-ANR5>3.0.CO;2-Z     Document Type: Article

References (49)

1. Replicative senescence: The human fibroblast comes of age
2. Replicative senescence: An old lives' tale?
3. Extension of life-span by introduction of telomerase into normal human cells
4. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
5. Replicative life-span of cultivated human cells: Effects of donor's age, tissue, and genotype
6. Chronologic and physiologic age effect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors
7. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes
8. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo
9. Telomere length predicts replicative capacity of human fibroblast
10. Telomere reduction in human colorectal carcinoma and with aging
11. Structure and function of telomeres
12. Telomeres shorten during aging of human fibroblasts
13. Telomere end-replication problem and cell aging
14. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts
15. Telomere loss: Mitotic clock or genetic time bomb?
16. In vivo loss of telomeric repeats with age in humans
17. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
18. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
19. Specific association of human telomerase activity with immortal cells and cancer
20. Telomerase activity in normal leukocytes and in hematologic malignancies
21. Telomerase activity associated with acquisition of malignancy in human colorectal cancer
22. Telomeres, telomerase, and immortality
23. Mechanisms of disease: Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
24. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
25. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence
26. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: Potential mechanisms of their deleterious effects on bone
27. Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats: An ultrastructural analysis
28. The effect of aging on bone formation in porous hydroxyapatite: Biochemical and histological analysis
29. Age-related changes in osteogenic stem cells in mice
30. Relationship between bone formation rate and osteoblastic surface on different subdivisions of the endosteal envelope in aging and osteoporosis
31. Bone-forming cells in clinical conditions
32. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation
33. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
34. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age
35. A rapid quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro
36. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors
37. Growth of human embryonic fibroblasts at clonal density: Concordance with results from mass cultures
38. Bone remodeling
39. Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: Lack of excessive telomere loss in osteoporotic patients
40. Rheumatoid synovitis and pannus
41. Periarticular osteopenia in adjuvant-induced arthritis: Role of interleukin-1 in decreased osteogenic and increased resorp tive potential of bone marrow cells
42. Regulation of osteoclast function
43. Modulation of osteoclast differentiation: Update 1995
44. Osteoclast differentiation factor is a ligand for osteoprogerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
45. Methotrexate osteopathy in rheumatic disease
46. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis
47. Telomerase catalytic subunit homologs from fission yeast and human
48. HEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization
49. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoma